David Matthew Nathan MD

Diabetes, Lipid Metabolism

Professor of Medicine, Massachusetts General Hospital

50 Staniford St3rd Floor S50 3Boston, MA 02114
Phone+1 617-726-2875
Fax+1 617-726-6781

Dr. Nathan is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nathan's full profile Already have an account?

Education & Training

Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 1975 - 1978
Icahn School of Medicine at Mount SinaiClass of 1975

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1978 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017

Clinical Trials

Diabetes Prevention Program Outcomes Study Start of enrollment: 1996 Jul 31
COMPLETED
PHASE3
Epidemiology of Diabetes Interventions and Complications (EDIC)
ACTIVE_NOT_RECRUITING
Gestational Diabetes Mellitus and Implications for Cardiovascular Disease Risk
UNKNOWN

Publications & Presentations

PubMed

A Conversation With Dr David Nathan: Goodbye to All That?
Melissa S Putman, David M Nathan
Endocrine Practice. 2026-08-01
Differences Between Glycemia Estimates from Hemoglobin A1c and Continuous Glucose Monitoring and Their Association with Complete Blood Counts.
Veronica Tozzo, David M Nathan, Heidi Krause-Steinrauf, John M Lachin, Mary E Larkin
Diabetes Technology & Therapeutics. 2026-05-01
2 citations
Shared and distinct metabolomics profiles associated with microvascular complications in the Diabetes Prevention Program Outcomes Study.
Wei Perng, Shiyu Shu, David M Nathan, Jose A Luchsinger, Robert E Gerszten
Diabetologia. 2026-01-01

Journal Articles

Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes
Vivian Fonseca, David M Nathan, Jonathan Newman, The Journal of Clinical Endocrinology and Metabolism

Lectures

2nd Annual Diabetes Symposium: New Advances and Innovations
Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 10/11/2013
2nd Annual Diabetes Symposium: New Advances and Innovations
Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 10/11/2013
1st Annual Diabetes Symposium: New Advances and Innovations
Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania - 9/28/2012

Press Mentions

ADLM 2026 Draws 17,000 Attendees to Explore Advances in Clinical Laboratory MedicineJuly 30th, 2026
Diabetes Association in Uproar After Members Expelled From Annual Meeting Over Protest of NIH CutsJune 9th, 2026
ADLM Names 2026 Laboratory Medicine Award WinnersMay 19th, 2026

Grant Support

Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD ProjectCOLUMBIA UNIVERSITY HEALTH SCIENCES2022–2027
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) StudyGEORGE WASHINGTON UNIVERSITY2012–2025
Diabetes Prevention Program Outcome Study - Phase 2National Institute Of Diabetes And Digestive And Kidney Diseases2009–2012
Glycemic Reduction Approaches For Treating Diabetes: An Effectiveness StudyNational Institute Of Diabetes And Digestive And Kidney Diseases2010–2011

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Similar Physicians & HCPs

William Crowley Jr., MD
EndoBoston, MA
Enrico Cagliero, MD
EndoBoston, MA
Steven Russell, MD
EndoBoston, MA
Jeanne Steppel-Reznik, MD
EndoBoston, MA
Paul Copeland, MD
EndoBoston, MA
Sean Burns, MD
EndoBoston, MA
Runhua Hou, MD
EndoBoston, MA
Rhonda Bentley-Lewis, MD
EndoBoston, MA
Alexander Soukas, MD
EndoBoston, MA
Klara Rosenquist, MD
EndoBoston, MA

Doximity / States / Massachusetts / Boston / David Nathan, MD

Dr. David Nathan, Dr. David Nathan, MD, Dr. D Nathan, Dr. David Matthew Nathan